Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy

Abstract

In a prospective randomised trial of argon laser photocoagulation in the management of central serous retinopathy, long-term follow-up (6·4 to 12·1 years) revealed no evidence that treatment significantly influenced the visual outcome as measured by the Snellen chart and by the Farnsworth-Munsell 100-hue test. Treatment did not reduce either the recurrence rate or the prevalence of chronic disease. Complications of treatment were uncommon. The justification for argon laser photocoagulation appears to be limited to the hastening of symptomatic relief by earlier resolution of serous detachment.